Unfortunately, the spectrum of clinical manifestations of SLE is so broad, and the individual patterns of disease so diverse – changing with time even in individual patients – that diagnosis ...

Cutaneous Lupus Erythematosus. Cutaneous manifestations occur in up to 80% of patients with lupus. Cutaneous LE may occur with SLE or independently, and can be seronegative for ANAs in the latter ...

EXTON, Pa., Dec. 21, 2010 /PRNewswire/ -- BioTrends Research Group, Inc. is pleased to announce the publication of a new syndicated report focused on the management and treatment of systemic lupus ...

June 19, 2009 (Copenhagen, Denmark) — New recommendations for the diagnosis and management of systemic lupus erythematosus (SLE) with neuropsychiatric manifestations were presented here at EULAR ...

Magnetic resonance imaging (MRI) findings such as inflammatory-type lesions and myelopathies are significantly associated with attribution of neuropsychiatric (NP) events to systemic lupus ...

More severe organ-threatening SLE manifestations Oral glucocorticoids 1–2 mg/kg prednisone (or equivalent) Addition of antimalarials and/or immunosuppressives for long-term management ...

Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has approved Phase IIb clinical trial of KPG ...

EXTON, PA, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The systemic lupus erythematosus (SLE) advanced treatment landscape is poised for evolution, with ...

HEFEI, China, April 28, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA ...

HEFEI, China, April 28, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has ...